Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Truist biotechnology analysts to hold an analyst/industry conference call » 09:25
09/20/21
09/20
09:25
09/20/21
09:25
EDIT

Editas Medicine

$63.31 /

+2.27 (+3.72%)

Biotech Analysts discuss…

Biotech Analysts discuss wet Age-Related Macular Degeneration (wAMD) and Leber Congenital Amaurosis 10 (LCA10) with a focus on EDIT-101 data on an Analyst/Industry conference call to be held on September 20 at 10 am.

ShowHide Related Items >><<
EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

  • 21
    Jan
EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

Conference/Events
Truist biotechnology analysts to hold an analyst/industry conference call » 04:55
09/20/21
09/20
04:55
09/20/21
04:55
EDIT

Editas Medicine

$63.31 /

+2.27 (+3.72%)

Biotech Analysts discuss…

Biotech Analysts discuss wet Age-Related Macular Degeneration (wAMD) and Leber Congenital Amaurosis 10 (LCA10) with a focus on EDIT-101 data on an Analyst/Industry conference call to be held on September 20 at 10 am.

ShowHide Related Items >><<
EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

  • 21
    Jan
EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

EDIT Editas Medicine
$63.31 /

+2.27 (+3.72%)

Over a week ago
On The Fly
Wall Street in Fives - Must Read Lists for Friday » 16:30
09/10/21
09/10
16:30
09/10/21
16:30
AAPL

Apple

$149.04 /

-5.08 (-3.30%)

, TCEHY

Tencent

$62.37 /

-0.89 (-1.41%)

, KKR

KKR

$62.76 /

-0.16 (-0.25%)

, DIS

Disney

$184.13 /

-1.775 (-0.95%)

, SONY

Sony

$110.37 /

+0.44 (+0.40%)

, BAC

Bank of America

$40.28 /

-0.65 (-1.59%)

, AFRM

Affirm

$123.75 /

+31.65 (+34.36%)

, APLS

Apellis

$34.98 /

-20.67 (-37.14%)

, ZS

Zscaler

$270.49 /

-9.86 (-3.52%)

, CI

Cigna

$204.64 /

-9.32 (-4.36%)

, FCX

Freeport McMoRan

$35.47 /

+0.665 (+1.91%)

, EDIT

Editas Medicine

$66.02 /

+1.43 (+2.21%)

, FMS

Fresenius Medical

$36.49 /

-1.705 (-4.46%)

, AMT

American Tower

$293.85 /

-2.9 (-0.98%)

, CCI

Crown Castle

$188.35 /

-4.05 (-2.10%)

, EQIX

Equinix

$844.29 /

-10.12 (-1.18%)

, BHC

Bausch Health

$28.45 /

-0.17 (-0.59%)

, FB

Facebook

$378.85 /

+1.005 (+0.27%)

, SONO

Sonos

$36.98 /

-0.7 (-1.86%)

, DBRG

DigitalBridge

$6.48 /

-0.045 (-0.69%)

, ENDP

Endo

$2.79 /

+0.68 (+32.30%)

, TIGR

UP Fintech

$14.56 /

+1.2 (+8.98%)

, IMPL

Impel NeuroPharma

$16.18 /

-4.93 (-23.35%)

, AOUT

American Outdoor Brands

$25.98 /

-0.24 (-0.92%)

, ALB

Albemarle

$241.21 /

-2.25 (-0.92%)

, KR

Kroger

$42.65 /

-3.5 (-7.58%)

, PLAY

Dave & Buster's

$35.83 /

+0.385 (+1.09%)

, TTWO

Take-Two

$153.93 /

-3.03 (-1.93%)

, TDC

Teradata

$51.11 /

-5.37 (-9.51%)

, SANW

S&W Seed

$2.35 /

+0.05 (+2.17%)

, INGR

Ingredion

$86.23 /

-0.04 (-0.05%)

Get caught up quickly on…

ShowHide Related Items >><<
ZS Zscaler
$270.49 /

-9.86 (-3.52%)

TTWO Take-Two
$153.93 /

-3.03 (-1.93%)

TIGR UP Fintech
$14.56 /

+1.2 (+8.98%)

TDC Teradata
$51.11 /

-5.37 (-9.51%)

TCEHY Tencent
$62.37 /

-0.89 (-1.41%)

SONY Sony
$110.37 /

+0.44 (+0.40%)

SONO Sonos
$36.98 /

-0.7 (-1.86%)

SANW S&W Seed
$2.35 /

+0.05 (+2.17%)

PLAY Dave & Buster's
$35.83 /

+0.385 (+1.09%)

KR Kroger
$42.65 /

-3.5 (-7.58%)

KKR KKR
$62.76 /

-0.16 (-0.25%)

INGR Ingredion
$86.23 /

-0.04 (-0.05%)

IMPL Impel NeuroPharma
$16.18 /

-4.93 (-23.35%)

FMS Fresenius Medical
$36.49 /

-1.705 (-4.46%)

FCX Freeport McMoRan
$35.47 /

+0.665 (+1.91%)

FB Facebook
$378.85 /

+1.005 (+0.27%)

EQIX Equinix
$844.29 /

-10.12 (-1.18%)

ENDP Endo
$2.79 /

+0.68 (+32.30%)

EDIT Editas Medicine
$66.02 /

+1.43 (+2.21%)

DIS Disney
$184.13 /

-1.775 (-0.95%)

DBRG DigitalBridge
$6.48 /

-0.045 (-0.69%)

CI Cigna
$204.64 /

-9.32 (-4.36%)

CCI Crown Castle
$188.35 /

-4.05 (-2.10%)

BHC Bausch Health
$28.45 /

-0.17 (-0.59%)

BAC Bank of America
$40.28 /

-0.65 (-1.59%)

APLS Apellis
$34.98 /

-20.67 (-37.14%)

AOUT American Outdoor Brands
$25.98 /

-0.24 (-0.92%)

AMT American Tower
$293.85 /

-2.9 (-0.98%)

ALB Albemarle
$241.21 /

-2.25 (-0.92%)

AFRM Affirm
$123.75 /

+31.65 (+34.36%)

AAPL Apple
$149.04 /

-5.08 (-3.30%)

AAPL Apple
$149.04 /

-5.08 (-3.30%)

09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
09/10/21 Wedbush
Wedbush says Apple injunction could boost earnings for mobile game makers
09/10/21 Baird
Apple ruling could be positive for mobile game publishers, says Baird
09/10/21 Piper Sandler
Apple court ruling not likely to materially impact business, says Piper Sandler
TCEHY Tencent
$62.37 /

-0.89 (-1.41%)

09/06/21 KGI Securities
Tencent initiated with an Outperform at KGI Securities
08/20/21 Erste Group
Tencent downgraded to Sell from Hold at Erste Group
08/19/21 Mizuho
Tencent price target lowered to HK$530 from HK$650 at Mizuho
KKR KKR
$62.76 /

-0.16 (-0.25%)

08/11/21 Deutsche Bank
KKR upgraded to Buy on durable earnings power at Deutsche Bank
08/11/21 Deutsche Bank
KKR upgraded to Buy from Hold at Deutsche Bank
08/05/21 JMP Securities
KKR upgraded to Outperform from Market Perform at JMP Securities
DIS Disney
$184.13 /

-1.775 (-0.95%)

09/09/21 Arete
Disney initiated with a Buy at Arete
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
08/27/21 Deutsche Bank
Disney price target lowered to $200 from $213 at Deutsche Bank
SONY Sony
$110.37 /

+0.44 (+0.40%)

07/27/21 Morgan Stanley
Sony upgraded to Overweight at Morgan Stanley on animation business growth
07/27/21 Morgan Stanley
Sony upgraded to Overweight from Equal Weight at Morgan Stanley
BAC Bank of America
$40.28 /

-0.65 (-1.59%)

07/19/21 Odeon Capital
Bank of America downgraded to Hold from Buy at Odeon Capital
07/06/21 Keefe Bruyette
Bank of America assumed with a Market Perform at Keefe Bruyette
06/02/21 Truist
Bank of America initiated with a Buy at Truist
05/04/21
Fly Intel: Top five analyst downgrades
AFRM Affirm
$123.75 /

+31.65 (+34.36%)

09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
09/10/21 Truist
Affirm price target raised to $150 from $120 at Truist
09/10/21 Morgan Stanley
Affirm price target raised to $140 from $120 at Morgan Stanley
09/10/21 DA Davidson
Affirm price target raised to $110 from $85 at DA Davidson
APLS Apellis
$34.98 /

-20.67 (-37.14%)

09/10/21 BMO Capital
Apellis price target lowered to $69 from $89 at BMO Capital
09/10/21 Cowen
Cowen says Apellis data 'could not be more positive' for Iveric, ups target
09/10/21 Jefferies
Jefferies continues to see Apellis' pegcetacoplan as approvable in GA
09/10/21 Needham
Apellis price target lowered to $70 from $85 at Needham
ZS Zscaler
$270.49 /

-9.86 (-3.52%)

09/10/21 Loop Capital
Zscaler price target raised to $280 from $250 at Loop Capital
09/10/21 BMO Capital
Zscaler price target raised to $315 from $250 at BMO Capital
09/10/21 Cowen
Zscaler price target raised to $314 from $255 at Cowen
09/10/21 Truist
Zscaler price target raised to $325 from $225 at Truist
CI Cigna
$204.64 /

-9.32 (-4.36%)

09/10/21
Fly Intel: Top five analyst downgrades
09/10/21 BofA
Cigna downgraded to Underperform from Buy at BofA
09/09/21 Cowen
Cigna initiated with a Market Perform at Cowen
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
FCX Freeport McMoRan
$35.47 /

+0.665 (+1.91%)

09/10/21 Credit Suisse
Credit Suisse downgrades Freeport McMoRan to sell on copper price risk
09/10/21 Credit Suisse
Freeport McMoRan downgraded to Underperform from Neutral at Credit Suisse
07/23/21 Deutsche Bank
Freeport McMoRan price target lowered to $47 from $50 at Deutsche Bank
EDIT Editas Medicine
$66.02 /

+1.43 (+2.21%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
FMS Fresenius Medical
$36.49 /

-1.705 (-4.46%)

09/10/21 Barclays
Fresenius Medical downgraded to Equal Weight from Overweight at Barclays
09/10/21 JPMorgan
Fresenius Medical downgraded to Underweight from Neutral at JPMorgan
08/11/21 JPMorgan
Fresenius Medical price target raised to EUR 61.30 from EUR 58.80 at JPMorgan
08/04/21 Societe Generale
Fresenius Medical price target raised to EUR 71 from EUR 64 at Societe Generale
AMT American Tower
$293.85 /

-2.9 (-0.98%)

09/10/21 Morgan Stanley
American Tower price target raised to $316 from $270 at Morgan Stanley
09/10/21 Oppenheimer
American Tower downgraded to Perform from Outperform at Oppenheimer
08/12/21 Argus
American Tower price target raised to $300 from $288 at Argus
08/03/21 Raymond James
American Tower price target raised to $296 from $261 at Raymond James
CCI Crown Castle
$188.35 /

-4.05 (-2.10%)

09/10/21 Morgan Stanley
Crown Castle price target raised to $213 from $204 at Morgan Stanley
09/10/21 Oppenheimer
Crown Castle downgraded to Perform from Outperform at Oppenheimer
07/19/21 KeyBanc
Crown Castle price target raised to $224 from $207 at KeyBanc
07/13/21 LightShed Partners
Crown Castle downgraded to Neutral from Buy at LightShed Partners
EQIX Equinix
$844.29 /

-10.12 (-1.18%)

09/10/21 Oppenheimer
Equinix downgraded to Perform from Outperform at Oppenheimer
08/26/21 Citi
Switch added to 'positive Catalyst Watch list' at Citi
07/29/21 Truist
Equinix price target raised to $925 from $900 at Truist
07/29/21 Credit Suisse
Equinix price target raised to $942 from $907 at Credit Suisse
BHC Bausch Health
$28.45 /

-0.17 (-0.59%)

08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
08/04/21 Barclays
Bausch Health price target lowered to $31 from $35 at Barclays
07/06/21 Spin-Off Research
Bausch Health initiated with a Buy at Spin-Off Research
06/02/21 Roth Capital
Clearside success with Xipere can derisk pipeline, says Roth Capital
FB Facebook
$378.85 /

+1.005 (+0.27%)

09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
09/09/21 HSBC
Facebook price target raised to $300 from $275 at HSBC
09/01/21
Fly Intel: Top five analyst downgrades
09/01/21 Rosenblatt
Facebook downgraded to Neutral from Buy at Rosenblatt
SONO Sonos
$36.98 /

-0.7 (-1.86%)

08/16/21
Fly Intel: Top five analyst upgrades
08/16/21 Jefferies
Sonos upgraded to Buy from Hold at Jefferies
05/25/21 Stifel
Plexus warning may be signal that supply constraints will worsen, says Stifel
05/13/21 Morgan Stanley
Morgan Stanley bumps Sonos price target to $47 after 'another beat and raise'
DBRG DigitalBridge
$6.48 /

-0.045 (-0.69%)

08/09/21 Raymond James
Raymond James starts DigitalBridge at Outperform on shift to digital business
08/09/21 Raymond James
DigitalBridge initiated with an Outperform at Raymond James
06/23/21 Cowen
DigitalBridge price target raised to $9.25 from $7.25 at Cowen
06/23/21 B. Riley
DigitalBridge price target raised to $12 from $11 at B. Riley
ENDP Endo
$2.79 /

+0.68 (+32.30%)

08/31/21 Piper Sandler
Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss
08/31/21 Piper Sandler
Endo downgraded to Neutral from Overweight at Piper Sandler
08/31/21 Cantor Fitzgerald
Eagle court victory over Par a 'big step,' says Cantor Fitzgerald
07/12/21 Citi
Citi remains buyer of Endo, sees opioid risk as manageable
TIGR UP Fintech
$14.56 /

+1.2 (+8.98%)

07/13/21 Goldman Sachs
UP Fintech initiated with a Sell at Goldman Sachs
03/04/21 CICC
UP Fintech initiated with an Outperform at CICC
02/26/21 Citi
UP Fintech price target raised to $38.60 from $8.30 at Citi
IMPL Impel NeuroPharma
$16.18 /

-4.93 (-23.35%)

09/03/21 Cowen
Impel NeuroPharma price target raised to $55 from $35 at Cowen
05/18/21 Wedbush
Wedbush bullish on Impel NeuroPharma, initiates with an Outperform
05/18/21 Wedbush
Impel NeuroPharma initiated with an Outperform at Wedbush
05/18/21 Guggenheim
Impel NeuroPharma initiated with a Buy at Guggenheim
AOUT American Outdoor Brands
$25.98 /

-0.24 (-0.92%)

09/10/21 B. Riley
American Outdoor guidance reiteration being misinterpreted, says B. Riley
07/16/21 Lake Street
American Outdoor Brands price target raised to $40 from $37 at Lake Street
07/16/21 B. Riley
American Outdoor Brands price target raised to $46 from $44 at B. Riley
07/02/21 B. Riley
American Outdoor, Vista Outdoor setups remain attractive, says B. Riley
ALB Albemarle
$241.21 /

-2.25 (-0.92%)

09/08/21
Fly Intel: Top five analyst upgrades
09/08/21 Berenberg
Albemarle upgraded to Buy from Sell at Berenberg
08/30/21 Cowen
Albemarle price target raised to $260 from $180 at Cowen
08/23/21 Loop Capital
Albemarle price target raised to $253 from $208 at Loop Capital
KR Kroger
$42.65 /

-3.5 (-7.58%)

09/07/21 Wells Fargo
Kroger price target raised to $46 from $39 at Wells Fargo
06/22/21 Northcoast
Kroger price target raised to $46 from $41 at Northcoast
06/21/21 Deutsche Bank
Kroger price target raised to $41 from $36 at Deutsche Bank
06/18/21 MKM Partners
Kroger price target raised to $40 from $35 at MKM Partners
PLAY Dave & Buster's
$35.83 /

+0.385 (+1.09%)

09/10/21 BMO Capital
Dave & Buster's price target raised to $58 from $54 at BMO Capital
09/02/21 Wells Fargo
Dave & Buster's price target lowered to $38 from $45 at Wells Fargo
08/30/21
Fly Intel: Top five analyst downgrades
08/30/21 Raymond James
Raymond James reiterates Strong Buy rating on Dave & Buster's ahead of earnings
TTWO Take-Two
$153.93 /

-3.03 (-1.93%)

08/31/21 Jefferies
China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
08/20/21 Benchmark
Take-Two price target lowered to $200 from $250 at Benchmark
TDC Teradata
$51.11 /

-5.37 (-9.51%)

09/10/21 JMP Securities
Teradata price target raised to $78 from $70 at JMP Securities
09/08/21 Stifel
Stifel says Parker-Hannifin's Meggitt bid has 'smoother route' with Teradata out
09/02/21
Fly Intel: Top five analyst initiations
09/02/21 Craig-Hallum
Teradata initiated with a Buy at Craig-Hallum
SANW S&W Seed
$2.35 /

+0.05 (+2.17%)

09/10/21 Lake Street
S&W Seed pact with Ingredion a 'potential needle-mover,' says Lake Street
04/16/21 Lake Street
S&W Seed initiated with a Buy at Lake Street
INGR Ingredion
$86.23 /

-0.04 (-0.05%)

05/05/21 Stephens
Stephens downgrades Ingredion to Equal Weight on lower beat and raise potential
05/05/21 Stephens
Ingredion downgraded to Equal Weight from Overweight at Stephens
ZS Zscaler
$270.49 /

-9.86 (-3.52%)

TTWO Take-Two
$153.93 /

-3.03 (-1.93%)

TIGR UP Fintech
$14.56 /

+1.2 (+8.98%)

TDC Teradata
$51.11 /

-5.37 (-9.51%)

SONY Sony
$110.37 /

+0.44 (+0.40%)

SONO Sonos
$36.98 /

-0.7 (-1.86%)

SANW S&W Seed
$2.35 /

+0.05 (+2.17%)

PLAY Dave & Buster's
$35.83 /

+0.385 (+1.09%)

KR Kroger
$42.65 /

-3.5 (-7.58%)

KKR KKR
$62.76 /

-0.16 (-0.25%)

INGR Ingredion
$86.23 /

-0.04 (-0.05%)

IMPL Impel NeuroPharma
$16.18 /

-4.93 (-23.35%)

FCX Freeport McMoRan
$35.47 /

+0.665 (+1.91%)

FB Facebook
$378.85 /

+1.005 (+0.27%)

EQIX Equinix
$844.29 /

-10.12 (-1.18%)

ENDP Endo
$2.79 /

+0.68 (+32.30%)

EDIT Editas Medicine
$66.02 /

+1.43 (+2.21%)

DIS Disney
$184.13 /

-1.775 (-0.95%)

DBRG DigitalBridge
$6.48 /

-0.045 (-0.69%)

CI Cigna
$204.64 /

-9.32 (-4.36%)

CCI Crown Castle
$188.35 /

-4.05 (-2.10%)

BHC Bausch Health
$28.45 /

-0.17 (-0.59%)

BAC Bank of America
$40.28 /

-0.65 (-1.59%)

APLS Apellis
$34.98 /

-20.67 (-37.14%)

AOUT American Outdoor Brands
$25.98 /

-0.24 (-0.92%)

AMT American Tower
$293.85 /

-2.9 (-0.98%)

ALB Albemarle
$241.21 /

-2.25 (-0.92%)

AFRM Affirm
$123.75 /

+31.65 (+34.36%)

AAPL Apple
$149.04 /

-5.08 (-3.30%)

  • 10
    Sep
  • 09
    Jun
  • 06
    May
  • 23
    Apr
  • 04
    Feb
  • 21
    Jan
  • 13
    Jan
  • 11
    Nov
ZS Zscaler
$270.49 /

-9.86 (-3.52%)

TTWO Take-Two
$153.93 /

-3.03 (-1.93%)

TIGR UP Fintech
$14.56 /

+1.2 (+8.98%)

TCEHY Tencent
$62.37 /

-0.89 (-1.41%)

SONY Sony
$110.37 /

+0.44 (+0.40%)

SONO Sonos
$36.98 /

-0.7 (-1.86%)

KR Kroger
$42.65 /

-3.5 (-7.58%)

KKR KKR
$62.76 /

-0.16 (-0.25%)

FCX Freeport McMoRan
$35.47 /

+0.665 (+1.91%)

FB Facebook
$378.85 /

+1.005 (+0.27%)

ENDP Endo
$2.79 /

+0.68 (+32.30%)

DIS Disney
$184.13 /

-1.775 (-0.95%)

DBRG DigitalBridge
$6.48 /

-0.045 (-0.69%)

CI Cigna
$204.64 /

-9.32 (-4.36%)

CCI Crown Castle
$188.35 /

-4.05 (-2.10%)

BHC Bausch Health
$28.45 /

-0.17 (-0.59%)

BAC Bank of America
$40.28 /

-0.65 (-1.59%)

AOUT American Outdoor Brands
$25.98 /

-0.24 (-0.92%)

ALB Albemarle
$241.21 /

-2.25 (-0.92%)

AFRM Affirm
$123.75 /

+31.65 (+34.36%)

AAPL Apple
$149.04 /

-5.08 (-3.30%)

ZS Zscaler
$270.49 /

-9.86 (-3.52%)

TIGR UP Fintech
$14.56 /

+1.2 (+8.98%)

TDC Teradata
$51.11 /

-5.37 (-9.51%)

TCEHY Tencent
$62.37 /

-0.89 (-1.41%)

SONY Sony
$110.37 /

+0.44 (+0.40%)

SONO Sonos
$36.98 /

-0.7 (-1.86%)

PLAY Dave & Buster's
$35.83 /

+0.385 (+1.09%)

KR Kroger
$42.65 /

-3.5 (-7.58%)

KKR KKR
$62.76 /

-0.16 (-0.25%)

IMPL Impel NeuroPharma
$16.18 /

-4.93 (-23.35%)

FCX Freeport McMoRan
$35.47 /

+0.665 (+1.91%)

FB Facebook
$378.85 /

+1.005 (+0.27%)

ENDP Endo
$2.79 /

+0.68 (+32.30%)

EDIT Editas Medicine
$66.02 /

+1.43 (+2.21%)

DBRG DigitalBridge
$6.48 /

-0.045 (-0.69%)

CI Cigna
$204.64 /

-9.32 (-4.36%)

BHC Bausch Health
$28.45 /

-0.17 (-0.59%)

BAC Bank of America
$40.28 /

-0.65 (-1.59%)

APLS Apellis
$34.98 /

-20.67 (-37.14%)

AOUT American Outdoor Brands
$25.98 /

-0.24 (-0.92%)

AFRM Affirm
$123.75 /

+31.65 (+34.36%)

AAPL Apple
$149.04 /

-5.08 (-3.30%)

ZS Zscaler
$270.49 /

-9.86 (-3.52%)

TTWO Take-Two
$153.93 /

-3.03 (-1.93%)

TIGR UP Fintech
$14.56 /

+1.2 (+8.98%)

TDC Teradata
$51.11 /

-5.37 (-9.51%)

SONY Sony
$110.37 /

+0.44 (+0.40%)

SONO Sonos
$36.98 /

-0.7 (-1.86%)

PLAY Dave & Buster's
$35.83 /

+0.385 (+1.09%)

KR Kroger
$42.65 /

-3.5 (-7.58%)

KKR KKR
$62.76 /

-0.16 (-0.25%)

FCX Freeport McMoRan
$35.47 /

+0.665 (+1.91%)

FB Facebook
$378.85 /

+1.005 (+0.27%)

EQIX Equinix
$844.29 /

-10.12 (-1.18%)

ENDP Endo
$2.79 /

+0.68 (+32.30%)

EDIT Editas Medicine
$66.02 /

+1.43 (+2.21%)

DIS Disney
$184.13 /

-1.775 (-0.95%)

DBRG DigitalBridge
$6.48 /

-0.045 (-0.69%)

BHC Bausch Health
$28.45 /

-0.17 (-0.59%)

BAC Bank of America
$40.28 /

-0.65 (-1.59%)

APLS Apellis
$34.98 /

-20.67 (-37.14%)

AOUT American Outdoor Brands
$25.98 /

-0.24 (-0.92%)

ALB Albemarle
$241.21 /

-2.25 (-0.92%)

AFRM Affirm
$123.75 /

+31.65 (+34.36%)

AAPL Apple
$149.04 /

-5.08 (-3.30%)

AAPL Apple
$149.04 /

-5.08 (-3.30%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:26
09/10/21
09/10
12:26
09/10/21
12:26
AAPL

Apple

$150.27 /

-3.85 (-2.50%)

, BAC

Bank of America

$40.62 /

-0.315 (-0.77%)

, AFRM

Affirm

$121.63 /

+29.53 (+32.06%)

, APLS

Apellis

$31.02 /

-24.63 (-44.26%)

, ZS

Zscaler

$276.16 /

-4.19 (-1.49%)

, BHC

Bausch Health

$28.44 /

-0.18 (-0.63%)

, FB

Facebook

$381.22 /

+3.375 (+0.89%)

, TSLA

Tesla

$755.45 /

+0.58 (+0.08%)

, SPOT

Spotify

$250.91 /

+4.73 (+1.92%)

, ENDP

Endo

$2.85 /

+0.74 (+35.15%)

, SANW

S&W Seed

$2.40 /

+0.1 (+4.35%)

, INGR

Ingredion

$86.58 /

+0.31 (+0.36%)

, TIGR

UP Fintech

$15.22 /

+1.86 (+13.92%)

, IMPL

Impel NeuroPharma

$16.69 /

-4.42 (-20.94%)

, AOUT

American Outdoor Brands

$26.88 /

+0.66 (+2.52%)

, ALB

Albemarle

$247.60 /

+4.14 (+1.70%)

, KR

Kroger

$42.62 /

-3.53 (-7.65%)

, PRCH

Porch Group

$22.73 /

+0.4 (+1.79%)

, TTWO

Take-Two

$154.29 /

-2.67 (-1.70%)

, TDC

Teradata

$51.11 /

-5.365 (-9.50%)

, TCEHY

Tencent

$63.26 /

-1.85 (-2.84%)

, KKR

KKR

$62.62 /

-0.3 (-0.48%)

, DIS

Disney

$186.47 /

+0.57 (+0.31%)

, SONY

Sony

$111.40 /

+1.47 (+1.34%)

, CI

Cigna

$205.04 /

-8.92 (-4.17%)

, FCX

Freeport McMoRan

$36.24 /

+1.435 (+4.12%)

, EDIT

Editas Medicine

$66.04 /

+1.45 (+2.24%)

, FMS

Fresenius Medical

$36.62 /

-1.57 (-4.11%)

, AMT

American Tower

$294.42 /

-2.33 (-0.79%)

, CCI

Crown Castle

$190.35 /

-2.05 (-1.07%)

, EQIX

Equinix

$844.85 /

-9.56 (-1.12%)

Get caught up quickly on…

ShowHide Related Items >><<
ZS Zscaler
$276.16 /

-4.19 (-1.49%)

TTWO Take-Two
$154.29 /

-2.67 (-1.70%)

TSLA Tesla
$755.45 /

+0.58 (+0.08%)

TIGR UP Fintech
$15.22 /

+1.86 (+13.92%)

TDC Teradata
$51.11 /

-5.365 (-9.50%)

TCEHY Tencent
$63.26 /

-1.85 (-2.84%)

SPOT Spotify
$250.91 /

+4.73 (+1.92%)

SONY Sony
$111.40 /

+1.47 (+1.34%)

SANW S&W Seed
$2.40 /

+0.1 (+4.35%)

PRCH Porch Group
$22.73 /

+0.4 (+1.79%)

KR Kroger
$42.62 /

-3.53 (-7.65%)

KKR KKR
$62.62 /

-0.3 (-0.48%)

INGR Ingredion
$86.58 /

+0.31 (+0.36%)

IMPL Impel NeuroPharma
$16.69 /

-4.42 (-20.94%)

FMS Fresenius Medical
$36.62 /

-1.57 (-4.11%)

FCX Freeport McMoRan
$36.24 /

+1.435 (+4.12%)

FB Facebook
$381.22 /

+3.375 (+0.89%)

EQIX Equinix
$844.85 /

-9.56 (-1.12%)

ENDP Endo
$2.85 /

+0.74 (+35.15%)

EDIT Editas Medicine
$66.04 /

+1.45 (+2.24%)

DIS Disney
$186.47 /

+0.57 (+0.31%)

CI Cigna
$205.04 /

-8.92 (-4.17%)

CCI Crown Castle
$190.35 /

-2.05 (-1.07%)

BHC Bausch Health
$28.44 /

-0.18 (-0.63%)

BAC Bank of America
$40.62 /

-0.315 (-0.77%)

APLS Apellis
$31.02 /

-24.63 (-44.26%)

AOUT American Outdoor Brands
$26.88 /

+0.66 (+2.52%)

AMT American Tower
$294.42 /

-2.33 (-0.79%)

ALB Albemarle
$247.60 /

+4.14 (+1.70%)

AFRM Affirm
$121.63 /

+29.53 (+32.06%)

AAPL Apple
$150.27 /

-3.85 (-2.50%)

AAPL Apple
$150.27 /

-3.85 (-2.50%)

09/10/21
Apple has resolved Watch 7 quality issues, TFI's Ming-Chi Kuo says
09/09/21 Piper Sandler
Apple price target raised to $175 from $165 at Piper Sandler
09/08/21 Baird
Apple price target raised to $170 from $160 at Baird
09/08/21 Morgan Stanley
App Store headlines 'more bark than bite' for Apple, says Morgan Stanley
BAC Bank of America
$40.62 /

-0.315 (-0.77%)

07/19/21 Odeon Capital
Bank of America downgraded to Hold from Buy at Odeon Capital
07/06/21 Keefe Bruyette
Bank of America assumed with a Market Perform at Keefe Bruyette
06/02/21 Truist
Bank of America initiated with a Buy at Truist
05/04/21
Fly Intel: Top five analyst downgrades
AFRM Affirm
$121.63 /

+29.53 (+32.06%)

09/10/21 BofA
Affirm price target raised to $119 from $82 at BofA
09/10/21 Truist
Affirm price target raised to $150 from $120 at Truist
09/10/21 Morgan Stanley
Affirm price target raised to $140 from $120 at Morgan Stanley
09/10/21 DA Davidson
Affirm price target raised to $110 from $85 at DA Davidson
APLS Apellis
$31.02 /

-24.63 (-44.26%)

09/10/21 BMO Capital
Apellis price target lowered to $69 from $89 at BMO Capital
09/10/21 Cowen
Cowen says Apellis data 'could not be more positive' for Iveric, ups target
09/10/21 Jefferies
Jefferies continues to see Apellis' pegcetacoplan as approvable in GA
09/10/21 Needham
Apellis price target lowered to $70 from $85 at Needham
ZS Zscaler
$276.16 /

-4.19 (-1.49%)

09/10/21 Loop Capital
Zscaler price target raised to $280 from $250 at Loop Capital
09/10/21 BMO Capital
Zscaler price target raised to $315 from $250 at BMO Capital
09/10/21 Cowen
Zscaler price target raised to $314 from $255 at Cowen
09/10/21 Truist
Zscaler price target raised to $325 from $225 at Truist
BHC Bausch Health
$28.44 /

-0.18 (-0.63%)

08/04/21 JPMorgan
Bausch Health selloff on Solta IPO plans overdone, says JPMorgan
08/04/21 Barclays
Bausch Health price target lowered to $31 from $35 at Barclays
07/06/21 Spin-Off Research
Bausch Health initiated with a Buy at Spin-Off Research
06/02/21 Roth Capital
Clearside success with Xipere can derisk pipeline, says Roth Capital
FB Facebook
$381.22 /

+3.375 (+0.89%)

09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
09/09/21 HSBC
Facebook price target raised to $300 from $275 at HSBC
09/01/21
Fly Intel: Top five analyst downgrades
09/01/21 Rosenblatt
Facebook downgraded to Neutral from Buy at Rosenblatt
TSLA Tesla
$755.45 /

+0.58 (+0.08%)

09/10/21 Craig-Hallum
VIA Optronics price target lowered to $14 from $18 at Craig-Hallum
09/10/21 Piper Sandler
Aspen Aerogels initiated with Overweight, $58 target at Piper Sandler
09/08/21 GLJ Research
Tesla sales in China in August a 'big problem,' says GLJ Research
08/31/21 Bernstein
Apple car likely all-electric, not expected before 2025, says Bernstein
SPOT Spotify
$250.91 /

+4.73 (+1.92%)

09/07/21
Fly Intel: Top five analyst upgrades
09/07/21 KeyBanc
Spotify upgraded to Overweight on favorable dynamics at KeyBanc
09/07/21 KeyBanc
Spotify upgraded to Overweight from Sector Weight at KeyBanc
07/30/21 Truist
Spotify price target lowered to $270 from $290 at Truist
ENDP Endo
$2.85 /

+0.74 (+35.15%)

08/31/21 Piper Sandler
Endo downgraded to Neutral at Piper Sandler following Vasostrict ruling loss
08/31/21 Piper Sandler
Endo downgraded to Neutral from Overweight at Piper Sandler
08/31/21 Cantor Fitzgerald
Eagle court victory over Par a 'big step,' says Cantor Fitzgerald
07/12/21 Citi
Citi remains buyer of Endo, sees opioid risk as manageable
SANW S&W Seed
$2.40 /

+0.1 (+4.35%)

09/10/21 Lake Street
S&W Seed pact with Ingredion a 'potential needle-mover,' says Lake Street
04/16/21 Lake Street
S&W Seed initiated with a Buy at Lake Street
INGR Ingredion
$86.58 /

+0.31 (+0.36%)

05/05/21 Stephens
Stephens downgrades Ingredion to Equal Weight on lower beat and raise potential
05/05/21 Stephens
Ingredion downgraded to Equal Weight from Overweight at Stephens
TIGR UP Fintech
$15.22 /

+1.86 (+13.92%)

07/13/21 Goldman Sachs
UP Fintech initiated with a Sell at Goldman Sachs
03/04/21 CICC
UP Fintech initiated with an Outperform at CICC
02/26/21 Citi
UP Fintech price target raised to $38.60 from $8.30 at Citi
IMPL Impel NeuroPharma
$16.69 /

-4.42 (-20.94%)

09/03/21 Cowen
Impel NeuroPharma price target raised to $55 from $35 at Cowen
05/18/21 Wedbush
Wedbush bullish on Impel NeuroPharma, initiates with an Outperform
05/18/21 Wedbush
Impel NeuroPharma initiated with an Outperform at Wedbush
05/18/21 Guggenheim
Impel NeuroPharma initiated with a Buy at Guggenheim
AOUT American Outdoor Brands
$26.88 /

+0.66 (+2.52%)

09/10/21 B. Riley
American Outdoor guidance reiteration being misinterpreted, says B. Riley
07/16/21 Lake Street
American Outdoor Brands price target raised to $40 from $37 at Lake Street
07/16/21 B. Riley
American Outdoor Brands price target raised to $46 from $44 at B. Riley
07/02/21 B. Riley
American Outdoor, Vista Outdoor setups remain attractive, says B. Riley
ALB Albemarle
$247.60 /

+4.14 (+1.70%)

09/08/21
Fly Intel: Top five analyst upgrades
09/08/21 Berenberg
Albemarle upgraded to Buy from Sell at Berenberg
08/30/21 Cowen
Albemarle price target raised to $260 from $180 at Cowen
08/23/21 Loop Capital
Albemarle price target raised to $253 from $208 at Loop Capital
KR Kroger
$42.62 /

-3.53 (-7.65%)

09/07/21 Wells Fargo
Kroger price target raised to $46 from $39 at Wells Fargo
06/22/21 Northcoast
Kroger price target raised to $46 from $41 at Northcoast
06/21/21 Deutsche Bank
Kroger price target raised to $41 from $36 at Deutsche Bank
06/18/21 MKM Partners
Kroger price target raised to $40 from $35 at MKM Partners
PRCH Porch Group
$22.73 /

+0.4 (+1.79%)

09/10/21 Benchmark
Porch Group price target raised to $30 from $26 at Benchmark
09/10/21 Stephens
Porch Group acquisitions 'two more smart deals,' says Stephens
08/17/21 Benchmark
Porch.com likely not done raising guidance, says Benchmark
06/28/21 Oppenheimer
Porch.com initiated with an Outperform at Oppenheimer
TTWO Take-Two
$154.29 /

-2.67 (-1.70%)

08/31/21 Jefferies
China crackdown 'more serious' for Roblox than U.S. publishers, says Jefferies
08/20/21 Benchmark
Take-Two price target lowered to $200 from $250 at Benchmark
08/16/21 Truist
Take-Two price target lowered to $200 from $220 at Truist
08/03/21 MKM Partners
Take-Two price target lowered to $180 from $185 at MKM Partners
TDC Teradata
$51.11 /

-5.365 (-9.50%)

09/10/21 JMP Securities
Teradata price target raised to $78 from $70 at JMP Securities
09/08/21 Stifel
Stifel says Parker-Hannifin's Meggitt bid has 'smoother route' with Teradata out
09/02/21
Fly Intel: Top five analyst initiations
09/02/21 Craig-Hallum
Teradata initiated with a Buy at Craig-Hallum
TCEHY Tencent
$63.26 /

-1.85 (-2.84%)

09/06/21 KGI Securities
Tencent initiated with an Outperform at KGI Securities
08/20/21 Erste Group
Tencent downgraded to Sell from Hold at Erste Group
08/19/21 Mizuho
Tencent price target lowered to HK$530 from HK$650 at Mizuho
08/05/21 Goldman Sachs
Tencent upgraded to Conviction Buy from Buy at Goldman Sachs
KKR KKR
$62.62 /

-0.3 (-0.48%)

08/11/21 Deutsche Bank
KKR upgraded to Buy on durable earnings power at Deutsche Bank
08/11/21 Deutsche Bank
KKR upgraded to Buy from Hold at Deutsche Bank
08/05/21 JMP Securities
KKR upgraded to Outperform from Market Perform at JMP Securities
08/04/21 Oppenheimer
KKR price target raised to $72 from $65 at Oppenheimer
DIS Disney
$186.47 /

+0.57 (+0.31%)

09/09/21 Arete
Disney initiated with a Buy at Arete
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
08/27/21 Deutsche Bank
Disney price target lowered to $200 from $213 at Deutsche Bank
08/16/21 Argus
Disney's TV, theme park, DTC businesses to gain further momentum, Argus says
SONY Sony
$111.40 /

+1.47 (+1.34%)

07/27/21 Morgan Stanley
Sony upgraded to Overweight at Morgan Stanley on animation business growth
07/27/21 Morgan Stanley
Sony upgraded to Overweight from Equal Weight at Morgan Stanley
CI Cigna
$205.04 /

-8.92 (-4.17%)

09/10/21
Fly Intel: Top five analyst downgrades
09/10/21 BofA
Cigna downgraded to Underperform from Buy at BofA
09/09/21 Cowen
Cigna initiated with a Market Perform at Cowen
09/08/21 Mizuho
Selloff in managed care sector overdone, says Mizuho
FCX Freeport McMoRan
$36.24 /

+1.435 (+4.12%)

09/10/21 Credit Suisse
Credit Suisse downgrades Freeport McMoRan to sell on copper price risk
09/10/21 Credit Suisse
Freeport McMoRan downgraded to Underperform from Neutral at Credit Suisse
07/23/21 Deutsche Bank
Freeport McMoRan price target lowered to $47 from $50 at Deutsche Bank
EDIT Editas Medicine
$66.04 /

+1.45 (+2.24%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
FMS Fresenius Medical
$36.62 /

-1.57 (-4.11%)

09/10/21 Barclays
Fresenius Medical downgraded to Equal Weight from Overweight at Barclays
09/10/21 JPMorgan
Fresenius Medical downgraded to Underweight from Neutral at JPMorgan
08/11/21 JPMorgan
Fresenius Medical price target raised to EUR 61.30 from EUR 58.80 at JPMorgan
08/04/21 Societe Generale
Fresenius Medical price target raised to EUR 71 from EUR 64 at Societe Generale
AMT American Tower
$294.42 /

-2.33 (-0.79%)

09/10/21 Morgan Stanley
American Tower price target raised to $316 from $270 at Morgan Stanley
09/10/21 Oppenheimer
American Tower downgraded to Perform from Outperform at Oppenheimer
08/12/21 Argus
American Tower price target raised to $300 from $288 at Argus
08/03/21 Raymond James
American Tower price target raised to $296 from $261 at Raymond James
CCI Crown Castle
$190.35 /

-2.05 (-1.07%)

09/10/21 Morgan Stanley
Crown Castle price target raised to $213 from $204 at Morgan Stanley
09/10/21 Oppenheimer
Crown Castle downgraded to Perform from Outperform at Oppenheimer
07/19/21 KeyBanc
Crown Castle price target raised to $224 from $207 at KeyBanc
07/13/21 LightShed Partners
Crown Castle downgraded to Neutral from Buy at LightShed Partners
EQIX Equinix
$844.85 /

-9.56 (-1.12%)

09/10/21 Oppenheimer
Equinix downgraded to Perform from Outperform at Oppenheimer
08/26/21 Citi
Switch added to 'positive Catalyst Watch list' at Citi
07/29/21 Truist
Equinix price target raised to $925 from $900 at Truist
07/29/21 Credit Suisse
Equinix price target raised to $942 from $907 at Credit Suisse
ZS Zscaler
$276.16 /

-4.19 (-1.49%)

TTWO Take-Two
$154.29 /

-2.67 (-1.70%)

TSLA Tesla
$755.45 /

+0.58 (+0.08%)

TIGR UP Fintech
$15.22 /

+1.86 (+13.92%)

TDC Teradata
$51.11 /

-5.365 (-9.50%)

SPOT Spotify
$250.91 /

+4.73 (+1.92%)

SONY Sony
$111.40 /

+1.47 (+1.34%)

SANW S&W Seed
$2.40 /

+0.1 (+4.35%)

PRCH Porch Group
$22.73 /

+0.4 (+1.79%)

KR Kroger
$42.62 /

-3.53 (-7.65%)

KKR KKR
$62.62 /

-0.3 (-0.48%)

INGR Ingredion
$86.58 /

+0.31 (+0.36%)

IMPL Impel NeuroPharma
$16.69 /

-4.42 (-20.94%)

FCX Freeport McMoRan
$36.24 /

+1.435 (+4.12%)

FB Facebook
$381.22 /

+3.375 (+0.89%)

EQIX Equinix
$844.85 /

-9.56 (-1.12%)

ENDP Endo
$2.85 /

+0.74 (+35.15%)

EDIT Editas Medicine
$66.04 /

+1.45 (+2.24%)

DIS Disney
$186.47 /

+0.57 (+0.31%)

CI Cigna
$205.04 /

-8.92 (-4.17%)

CCI Crown Castle
$190.35 /

-2.05 (-1.07%)

BHC Bausch Health
$28.44 /

-0.18 (-0.63%)

BAC Bank of America
$40.62 /

-0.315 (-0.77%)

APLS Apellis
$31.02 /

-24.63 (-44.26%)

AOUT American Outdoor Brands
$26.88 /

+0.66 (+2.52%)

AMT American Tower
$294.42 /

-2.33 (-0.79%)

ALB Albemarle
$247.60 /

+4.14 (+1.70%)

AFRM Affirm
$121.63 /

+29.53 (+32.06%)

AAPL Apple
$150.27 /

-3.85 (-2.50%)

  • 10
    Sep
  • 09
    Jun
  • 06
    May
  • 23
    Apr
  • 04
    Feb
  • 21
    Jan
  • 13
    Jan
  • 11
    Nov
ZS Zscaler
$276.16 /

-4.19 (-1.49%)

TTWO Take-Two
$154.29 /

-2.67 (-1.70%)

TSLA Tesla
$755.45 /

+0.58 (+0.08%)

TIGR UP Fintech
$15.22 /

+1.86 (+13.92%)

TCEHY Tencent
$63.26 /

-1.85 (-2.84%)

SPOT Spotify
$250.91 /

+4.73 (+1.92%)

SONY Sony
$111.40 /

+1.47 (+1.34%)

PRCH Porch Group
$22.73 /

+0.4 (+1.79%)

KR Kroger
$42.62 /

-3.53 (-7.65%)

KKR KKR
$62.62 /

-0.3 (-0.48%)

FCX Freeport McMoRan
$36.24 /

+1.435 (+4.12%)

FB Facebook
$381.22 /

+3.375 (+0.89%)

ENDP Endo
$2.85 /

+0.74 (+35.15%)

DIS Disney
$186.47 /

+0.57 (+0.31%)

CI Cigna
$205.04 /

-8.92 (-4.17%)

CCI Crown Castle
$190.35 /

-2.05 (-1.07%)

BHC Bausch Health
$28.44 /

-0.18 (-0.63%)

BAC Bank of America
$40.62 /

-0.315 (-0.77%)

AOUT American Outdoor Brands
$26.88 /

+0.66 (+2.52%)

ALB Albemarle
$247.60 /

+4.14 (+1.70%)

AFRM Affirm
$121.63 /

+29.53 (+32.06%)

AAPL Apple
$150.27 /

-3.85 (-2.50%)

ZS Zscaler
$276.16 /

-4.19 (-1.49%)

TTWO Take-Two
$154.29 /

-2.67 (-1.70%)

TSLA Tesla
$755.45 /

+0.58 (+0.08%)

TIGR UP Fintech
$15.22 /

+1.86 (+13.92%)

TDC Teradata
$51.11 /

-5.365 (-9.50%)

TCEHY Tencent
$63.26 /

-1.85 (-2.84%)

SPOT Spotify
$250.91 /

+4.73 (+1.92%)

SONY Sony
$111.40 /

+1.47 (+1.34%)

KR Kroger
$42.62 /

-3.53 (-7.65%)

IMPL Impel NeuroPharma
$16.69 /

-4.42 (-20.94%)

FCX Freeport McMoRan
$36.24 /

+1.435 (+4.12%)

FB Facebook
$381.22 /

+3.375 (+0.89%)

ENDP Endo
$2.85 /

+0.74 (+35.15%)

EDIT Editas Medicine
$66.04 /

+1.45 (+2.24%)

DIS Disney
$186.47 /

+0.57 (+0.31%)

CI Cigna
$205.04 /

-8.92 (-4.17%)

BHC Bausch Health
$28.44 /

-0.18 (-0.63%)

BAC Bank of America
$40.62 /

-0.315 (-0.77%)

APLS Apellis
$31.02 /

-24.63 (-44.26%)

AOUT American Outdoor Brands
$26.88 /

+0.66 (+2.52%)

ALB Albemarle
$247.60 /

+4.14 (+1.70%)

AFRM Affirm
$121.63 /

+29.53 (+32.06%)

AAPL Apple
$150.27 /

-3.85 (-2.50%)

ZS Zscaler
$276.16 /

-4.19 (-1.49%)

TTWO Take-Two
$154.29 /

-2.67 (-1.70%)

TSLA Tesla
$755.45 /

+0.58 (+0.08%)

TIGR UP Fintech
$15.22 /

+1.86 (+13.92%)

TDC Teradata
$51.11 /

-5.365 (-9.50%)

SPOT Spotify
$250.91 /

+4.73 (+1.92%)

SONY Sony
$111.40 /

+1.47 (+1.34%)

PRCH Porch Group
$22.73 /

+0.4 (+1.79%)

KR Kroger
$42.62 /

-3.53 (-7.65%)

KKR KKR
$62.62 /

-0.3 (-0.48%)

FCX Freeport McMoRan
$36.24 /

+1.435 (+4.12%)

FB Facebook
$381.22 /

+3.375 (+0.89%)

EQIX Equinix
$844.85 /

-9.56 (-1.12%)

ENDP Endo
$2.85 /

+0.74 (+35.15%)

EDIT Editas Medicine
$66.04 /

+1.45 (+2.24%)

DIS Disney
$186.47 /

+0.57 (+0.31%)

BHC Bausch Health
$28.44 /

-0.18 (-0.63%)

BAC Bank of America
$40.62 /

-0.315 (-0.77%)

APLS Apellis
$31.02 /

-24.63 (-44.26%)

AOUT American Outdoor Brands
$26.88 /

+0.66 (+2.52%)

ALB Albemarle
$247.60 /

+4.14 (+1.70%)

AFRM Affirm
$121.63 /

+29.53 (+32.06%)

AAPL Apple
$150.27 /

-3.85 (-2.50%)

Conference/Events
Truist biotechnology analysts to hold an analyst/industry conference call » 11:57
09/10/21
09/10
11:57
09/10/21
11:57
EDIT

Editas Medicine

$65.78 /

+1.19 (+1.84%)

Biotech Analysts discuss…

Biotech Analysts discuss wet Age-Related Macular Degeneration (wAMD) and Leber Congenital Amaurosis 10 (LCA10) with a focus on EDIT-101 data on an Analyst/Industry conference call to be held on September 20 at 10 am.

ShowHide Related Items >><<
EDIT Editas Medicine
$65.78 /

+1.19 (+1.84%)

EDIT Editas Medicine
$65.78 /

+1.19 (+1.84%)

09/10/21
Fly Intel: Top five analyst upgrades
09/10/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
EDIT Editas Medicine
$65.78 /

+1.19 (+1.84%)

  • 21
    Jan
EDIT Editas Medicine
$65.78 /

+1.19 (+1.84%)

EDIT Editas Medicine
$65.78 /

+1.19 (+1.84%)

Upgrade
Fly Intel: Top five analyst upgrades » 09:55
09/10/21
09/10
09:55
09/10/21
09:55
HBM

Hudbay Minerals

$6.35 /

+0.46 (+7.81%)

, ALLE

Allegion

$146.76 /

+3.45 (+2.41%)

, RXN

Rexnord

$64.02 /

+1.15 (+1.83%)

, CNO

CNO Financial

$23.91 /

+0.645 (+2.77%)

, EDIT

Editas Medicine

$66.60 /

+2.01 (+3.11%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Hudbay Minerals (HBM) upgraded to Outperform from Sector Perform at National Bank with analyst Shane Nagle saying the shares have declined 17% year-to-data on heightened political risks in Peru, but political risks will subside. 2. Allegion (ALLE) upgraded to Buy from Neutral at Goldman Sachs with analyst Joe Ritchie saying Allegion is a late cycle, non-residential manufacturer that is exposed to the "favorable thematic backdrop" of education stimulus. 3. Rexnord (RXN) upgraded to Buy from Neutral at Goldman Sachs with analyst Joe Ritchie saying Rexnord is a "high quality, water-levered story" with favorable non-residential exposure. 4. CNO Financial (CNO) upgraded to Overweight from Neutral at Piper Sandler with analyst John Barnidge thinking CNO will outperform the broader life insurance group over the next several quarters. 5. Editas Medicine (EDIT) upgraded to Outperform from Perform at Oppenheimer with analyst Jay Olson saying that he looks forward to EDIT-101 clinical results in LCA10, including safety data and preliminary efficacy endpoints, from low-dose and mid-dose cohorts at RD2021 this month, representing the first clinical data reported by Editas, and believes the cell medicine franchise and in vivo programs beyond ophthalmology offer upside in the longer term. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

HBM Hudbay Minerals
$6.35 /

+0.46 (+7.81%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

CNO CNO Financial
$23.91 /

+0.645 (+2.77%)

ALLE Allegion
$146.76 /

+3.45 (+2.41%)

HBM Hudbay Minerals
$6.35 /

+0.46 (+7.81%)

09/10/21 National Bank
Hudbay Minerals upgraded to Outperform from Sector Perform at National Bank
08/25/21 Credit Suisse
Hudbay Minerals price target lowered to C$11.50 from C$13 at Credit Suisse
07/19/21 Credit Suisse
Hudbay Minerals price target lowered to C$13 from C$14 at Credit Suisse
07/16/21 National Bank
Hudbay Minerals price target raised to C$14 from C$13 at National Bank
ALLE Allegion
$146.76 /

+3.45 (+2.41%)

09/10/21 Goldman Sachs
Allegion upgraded to Buy from Neutral at Goldman Sachs
07/23/21 Barclays
Allegion price target raised to EUR 176 from EUR 165 at Barclays
04/06/21
Fly Intel: Top five analyst upgrades
04/06/21 Barclays
Allegion upgraded to Overweight from Underweight at Barclays
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

09/10/21 Goldman Sachs
Rexnord upgraded to Buy from Neutral at Goldman Sachs
09/08/21 KeyBanc
Rexnord price target raised to $72 from $60 at KeyBanc
09/08/21 KeyBanc
Regal Beloit price target raised to $185 from $175 at KeyBanc
08/06/21 Baird
Rexnord price target raised to $70 from $66 at Baird
CNO CNO Financial
$23.91 /

+0.645 (+2.77%)

09/10/21 Piper Sandler
CNO Financial upgraded to Overweight from Neutral at Piper Sandler
07/08/21 Piper Sandler
CNO Financial price target lowered to $25 from $28 at Piper Sandler
03/31/21 Citi
CNO Financial price target raised to $25 from $23 at Citi
03/31/21 Piper Sandler
CNO Financial downgraded to Neutral from Overweight at Piper Sandler
EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

09/10/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

HBM Hudbay Minerals
$6.35 /

+0.46 (+7.81%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

CNO CNO Financial
$23.91 /

+0.645 (+2.77%)

ALLE Allegion
$146.76 /

+3.45 (+2.41%)

  • 21
    Jan
RXN Rexnord
$64.02 /

+1.15 (+1.83%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

EDIT Editas Medicine
$66.60 /

+2.01 (+3.11%)

ALLE Allegion
$146.76 /

+3.45 (+2.41%)

Upgrade
Editas Medicine upgraded to Outperform from Perform at Oppenheimer » 06:14
09/10/21
09/10
06:14
09/10/21
06:14
EDIT

Editas Medicine

$64.47 /

+0.11 (+0.17%)

Oppenheimer analyst Jay…

Oppenheimer analyst Jay Olson upgraded Editas Medicine to Outperform from Perform with a price target of $80, up from $42, ahead of initial clinical data from BRILLIANCE based on the analyst's favorable view of this readout in addition to overall pipeline progress. Olson tells investors in a research note that he looks forward to EDIT-101 clinical results in LCA10, including safety data and preliminary efficacy endpoints, from low-dose and mid-dose cohorts at RD2021 this month, representing the first clinical data reported by Editas, and believes the cell medicine franchise and in vivo programs beyond ophthalmology offer upside in the longer term.

ShowHide Related Items >><<
EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

09/09/21 Oppenheimer
Editas Medicine upgraded to Outperform from Perform at Oppenheimer
08/09/21
Fly Intel: Top five analyst upgrades
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

  • 21
    Jan
EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

Upgrade
Editas Medicine upgraded to Outperform from Perform at Oppenheimer » 16:27
09/09/21
09/09
16:27
09/09/21
16:27
EDIT

Editas Medicine

$64.47 /

+0.11 (+0.17%)

Oppenheimer analyst Jay…

Oppenheimer analyst Jay Olson upgraded Editas Medicine to Outperform from Perform with a price target of $80, up from $42.

ShowHide Related Items >><<
EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

08/09/21
Fly Intel: Top five analyst upgrades
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
08/05/21 Evercore ISI
Editas Medicine upgraded to Outperform from Underperform at Evercore ISI
EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

  • 21
    Jan
EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

EDIT Editas Medicine
$64.47 /

+0.11 (+0.17%)

Hot Stocks
Editas Medicine appoints Emma Reeve to board of directors » 09:18
09/08/21
09/08
09:18
09/08/21
09:18
EDIT

Editas Medicine

$66.73 /

-1.67 (-2.44%)

Editas Medicine announced…

Editas Medicine announced that it has appointed Emma Reeve to its Board of Directors. Most recently, Ms. Reeve served as Chief Financial Officer of Constellation Pharmaceuticals, Inc., a development-stage oncology company, prior to its acquisition by MorphoSys AG in 2021.

ShowHide Related Items >><<
EDIT Editas Medicine
$66.73 /

-1.67 (-2.44%)

EDIT Editas Medicine
$66.73 /

-1.67 (-2.44%)

08/09/21
Fly Intel: Top five analyst upgrades
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
08/05/21 Evercore ISI
Editas Medicine upgraded to Outperform from Underperform at Evercore ISI
EDIT Editas Medicine
$66.73 /

-1.67 (-2.44%)

  • 21
    Jan
EDIT Editas Medicine
$66.73 /

-1.67 (-2.44%)

EDIT Editas Medicine
$66.73 /

-1.67 (-2.44%)

Over a month ago
Hot Stocks
Editas Medicine presents data on SLEEK gene editing technology » 16:24
08/20/21
08/20
16:24
08/20/21
16:24
EDIT

Editas Medicine

$60.36 /

+2.32 (+4.00%)

Editas Medicine announced…

Editas Medicine announced data on a new gene editing technology termed SLEEK. The company reported these data in an oral presentation at Cold Spring Harbor Laboratory's Genome Engineering: CRISPR Frontiers meeting, being held virtually August 18-20, 2021. Despite major progress in achieving gene disruption, efficient knock-in of transgenes continues to be a significant challenge for the gene editing field. To solve this challenge, SLEEK was developed enabling high knock-in efficiencies with different transgenes while also ensuring robust, transgene expression. Editas Medicine believes that SLEEK may enable the development of next generation cell therapeutics for cancer and other serious diseases. New preclinical data demonstrated that SLEEK results in the knock-in of multiple clinically relevant transgenes through a proprietary process that selects for cells containing the knock-in cargo. In addition, high percentage knock-in efficiencies were enabled by Editas Medicine's proprietary engineered AsCas12a nuclease. More than 90 percent knock-in efficiencies were observed in various clinically relevant target cells, including iPSCs, T cells, and NK cells. Additionally, SLEEK may be used to fine-tune the expression levels of transgene cargos, an important attribute of next-generation cell therapy medicines. "We find the new gene editing SLEEK technology to have immense potential, as it enables nearly 100 percent knock-in of functional transgene cargos at specific locations in the genome, which we believe to be the highest in the gene editing field across multiple cell types. We believe that this novel technology has broad applications and may result in substantially improved gene edited cell medicines, including for novel CAR-T and CAR-NK cell therapies," said Mark S. Shearman, Ph.D., Executive Vice President and Chief Scientific Officer, Editas Medicine. "We believe SLEEK is an optimal approach to achieve highly efficient multi-transgene knock-in for the next generation of cell therapy medicines, and we are leveraging this technology across many oncology programs, including for treatment of a variety of solid tumors."

ShowHide Related Items >><<
EDIT Editas Medicine
$60.36 /

+2.32 (+4.00%)

EDIT Editas Medicine
$60.36 /

+2.32 (+4.00%)

08/09/21
Fly Intel: Top five analyst upgrades
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
08/09/21 Truist
Editas Medicine upgraded to Buy from Hold at Truist
08/05/21 Evercore ISI
Editas Medicine upgraded to Outperform from Underperform at Evercore ISI
EDIT Editas Medicine
$60.36 /

+2.32 (+4.00%)

  • 21
    Jan
EDIT Editas Medicine
$60.36 /

+2.32 (+4.00%)

EDIT Editas Medicine
$60.36 /

+2.32 (+4.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.